Trial Profile
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of bridging antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2012
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Tirofiban (Primary)
- Indications Coronary disorders; Coronary stent thrombosis
- Focus Therapeutic Use
- 21 Apr 2012 Status changed from recruiting to completed European Clinical Trials Database record.
- 21 Apr 2012 Actual end date (Mar 2007) added as reported by European Clinical Trials Database record.
- 18 Oct 2011 New trial record